Nationwide Fund Advisors lowered its stake in shares of Xylem Inc. (NYSE:XYL) by 2.9% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 49,722 shares of the company’s stock after selling 1,486 shares during the period. Nationwide Fund Advisors’ holdings in Xylem were worth $2,220,000 at the end of the most recent reporting period.
Several other institutional investors also recently bought and sold shares of the stock. Delaney Dennis R raised its position in shares of Xylem by 0.3% in the second quarter. Delaney Dennis R now owns 6,007 shares of the company’s stock worth $269,000 after buying an additional 20 shares during the period. Dempze Nancy E raised its position in shares of Xylem by 0.3% in the second quarter. Dempze Nancy E now owns 16,760 shares of the company’s stock worth $748,000 after buying an additional 50 shares during the period. Sanders Morris Harris Inc. raised its position in shares of Xylem by 1.3% in the second quarter. Sanders Morris Harris Inc. now owns 6,410 shares of the company’s stock worth $286,000 after buying an additional 85 shares during the period. Utah Retirement Systems raised its position in shares of Xylem by 0.3% in the second quarter. Utah Retirement Systems now owns 32,565 shares of the company’s stock worth $1,454,000 after buying an additional 100 shares during the period. Finally, Janney Montgomery Scott LLC raised its position in shares of Xylem by 0.3% in the second quarter. Janney Montgomery Scott LLC now owns 38,127 shares of the company’s stock worth $1,392,000 after buying an additional 126 shares during the period. 84.70% of the stock is owned by institutional investors.
Shares of Xylem Inc. (NYSE:XYL) traded up 0.82% during midday trading on Wednesday, hitting $50.11. The stock had a trading volume of 167,241 shares. The stock has a market cap of $8.98 billion, a PE ratio of 26.75 and a beta of 1.15. Xylem Inc. has a 52 week low of $31.67 and a 52 week high of $53.25. The stock has a 50-day moving average of $50.98 and a 200 day moving average of $46.34.
Xylem (NYSE:XYL) last posted its earnings results on Tuesday, August 2nd. The company reported $0.48 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.47 by $0.01. Xylem had a net margin of 9.22% and a return on equity of 16.41%. The company earned $932 million during the quarter, compared to analysts’ expectations of $927.69 million. During the same quarter in the previous year, the company posted $0.43 earnings per share. Xylem’s quarterly revenue was up 1.3% compared to the same quarter last year. Analysts anticipate that Xylem Inc. will post $2.04 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Wednesday, September 21st. Stockholders of record on Wednesday, August 31st were paid a $0.1549 dividend. This represents a $0.62 dividend on an annualized basis and a dividend yield of 1.25%. The ex-dividend date was Monday, August 29th. Xylem’s dividend payout ratio (DPR) is currently 33.16%.
A number of brokerages recently issued reports on XYL. Atlantic Securities raised Xylem from a “neutral” rating to an “overweight” rating and set a $54.00 price objective for the company in a report on Monday, August 22nd. RBC Capital Markets set a $51.00 price objective on Xylem and gave the stock a “buy” rating in a report on Tuesday, August 16th. Royal Bank Of Canada increased their price objective on Xylem from $47.00 to $51.00 and gave the stock an “outperform” rating in a report on Tuesday, August 16th. Canaccord Genuity reissued a “hold” rating and issued a $50.00 price objective (up from $45.00) on shares of Xylem in a report on Tuesday, August 16th. Finally, Barclays PLC increased their price objective on Xylem from $39.00 to $45.00 and gave the stock an “equal weight” rating in a report on Monday, July 18th. Nine investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of $45.00.
In other news, insider Colin R. Sabol sold 27,473 shares of Xylem stock in a transaction that occurred on Thursday, September 8th. The shares were sold at an average price of $50.91, for a total value of $1,398,650.43. Following the completion of the transaction, the insider now owns 65,530 shares in the company, valued at $3,336,132.30. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Tomas Brannemo sold 8,524 shares of Xylem stock in a transaction that occurred on Wednesday, August 17th. The shares were sold at an average price of $50.06, for a total transaction of $426,711.44. The disclosure for this sale can be found here. 0.77% of the stock is currently owned by insiders.
Xylem Inc is engaged in the design, manufacturing, and application of engineered technologies for the water industry. The Company is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.